Venture capital investment in Irish firms sank 34% last year

VC investment in Irish firms reached a four-year low in the final three months of 2023

Shorla Oncology, an Irish-founded healthcare start-up that develops pharmaceutical therapies to help cancer patients, raised the most funding in the last three months of the year, attracting $35 million

Venture capital (VC) deals in Ireland dropped to a four-year low in 2023 as global economic uncertainties saw investors remain cautious about their dealmaking activities.

According to KPMG’s latest Venture Pulse report, which analyses global and regional VC trends, VC investment in Ireland plummeted by 34 per cent last year.

The research found that VC investment in Irish firms declined to $764.06 million (€702.8 million) across 101 deals in 2023, down from $1.16 billion invested ...